Package 10370-207-11

{"route": ["ORAL"], "spl_id": "1e264688-469f-4a52-9cb7-a46488698a70", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0310370334118", "0310370208112", "0310370256113", "0310370207115"], "unii": ["U3H27498KS"], "rxcui": ["850087", "900156", "1098608", "1146690"], "spl_set_id": ["d5ec4d58-c669-4ab4-ba62-b71007536854"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Par Health USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10370-207-11)", "package_ndc": "10370-207-11", "marketing_start_date": "20260102"}], "brand_name": "Lamotrigine Extended-Release", "product_id": "10370-207_1e264688-469f-4a52-9cb7-a46488698a70", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "10370-207", "generic_name": "lamotrigine", "labeler_name": "Par Health USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "brand_name_suffix": "Extended-Release", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "100 mg/1"}], "application_number": "ANDA201374", "marketing_category": "ANDA", "marketing_start_date": "20260102", "listing_expiration_date": "20261231"}